1.73
price down icon2.53%   -0.05
 
loading

Opko Health Inc Borsa (OPK) Ultime notizie

pulisher
12:18 PM

OPKO Health (NASDAQ:OPK) Receives Buy Rating from HC Wainwright - MarketBeat

12:18 PM
pulisher
08:48 AM

Barrington Research Reaffirms Outperform Rating for OPKO Health (NASDAQ:OPK) - MarketBeat

08:48 AM
pulisher
07:34 AM

H.C. Wainwright maintains $3 target on Opko Health stock By Investing.com - Investing.com UK

07:34 AM
pulisher
Mar 12, 2025

Opko Health’s Strategic Divestiture and Financial Outlook Justifies Buy Rating - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Labcorp to buy Opko unit’s cancer test assets for up to $225M - MedTech Dive

Mar 12, 2025
pulisher
Mar 12, 2025

OPKO Health (NASDAQ:OPK) Shares Gap UpHere's What Happened - MarketBeat

Mar 12, 2025
pulisher
Mar 12, 2025

Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

OPKO Health’s Strategic Divestiture and Focus on Core Competencies Earns Buy Rating - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp to acquire select oncology testing assets for up to $225M - Modern Healthcare

Mar 11, 2025
pulisher
Mar 11, 2025

Opko Health Sells BioReference Assets to Labcorp - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp to buy certain assets of OPKO unit BioReference Health - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp to Acquire Oncology Testing Businesses of OPKO Health's BioReference Health Unit - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp to acquire BioReference Health assets for up to $225M - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

OPKO Health (NASDAQ:OPK) Stock Price Up 3.1%What's Next? - MarketBeat

Mar 11, 2025
pulisher
Mar 11, 2025

Q2 Earnings Estimate for OPKO Health Issued By HC Wainwright - MarketBeat

Mar 11, 2025
pulisher
Mar 10, 2025

OPKO Health (NASDAQ:OPK) Reaches New 52-Week HighShould You Buy? - MarketBeat

Mar 10, 2025
pulisher
Mar 08, 2025

OPKO Health (NASDAQ:OPK) Trading Up 3.1%Should You Buy? - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

OPKO Health (NASDAQ:OPK) Upgraded at StockNews.com - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Lowers Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

HC Wainwright Reaffirms Buy Rating for OPKO Health (NASDAQ:OPK) - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Invests $102,000 in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

OPKO Health (NASDAQ:OPK) delivers shareholders impressive 105% return over 1 year, surging 17% in the last week alone - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

The OPKO Health, Inc. (NASDAQ:OPK) Full-Year Results Are Out And Analysts Have Published New Forecasts - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

Analyst Estimates: Here's What Brokers Think Of OPKO Health, Inc. (NASDAQ:OPK) After Its Annual Report - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $115,312.14 in Stock - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

OPKO Health's (OPK) "Outperform" Rating Reaffirmed at Barrington Research - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

OPKO Health (NASDAQ:OPK) Releases Quarterly Earnings Results - MarketBeat

Mar 04, 2025
pulisher
Mar 03, 2025

OPKO HEALTH, INC. SEC 10-K Report - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

OPKO Health (NASDAQ:OPK) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Mar 03, 2025
pulisher
Mar 03, 2025

OPKO Health’s (OPK) Outperform Rating Reiterated at Barrington Research - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

OPKO Health (NASDAQ:OPK) Reaches New 1-Year High on Strong Earnings - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

OPKO Health (NASDAQ:OPK) Reaches New 52-Week High on Strong Earnings - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

OPKO Health Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Quote - OPKO Health, Inc.

Feb 28, 2025
pulisher
Feb 28, 2025

Opko Health stock hits 52-week high at $1.76 amid robust gains - Investing.com Australia

Feb 28, 2025
pulisher
Feb 28, 2025

OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - Yahoo Finance Australia

Feb 28, 2025
pulisher
Feb 28, 2025

Opko Health Buy Rating: Strong Q4 Performance, Positive Guidance, and Strategic Growth Initiatives - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Opko Health stock hits 52-week high at $1.76 amid robust gains By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

OPKO Health, Inc. (NASDAQ:OPK) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

OPKO Health: Q4 Earnings Snapshot - Thehour.com

Feb 28, 2025
$142.79
price down icon 1.01%
diagnostics_research DGX
$168.04
price up icon 0.88%
diagnostics_research LH
$237.25
price up icon 0.31%
diagnostics_research WAT
$365.07
price down icon 2.10%
diagnostics_research MTD
$1,202.50
price down icon 1.15%
diagnostics_research IQV
$182.62
price down icon 0.50%
Capitalizzazione:     |  Volume (24 ore):